Application of Antithrombotic Drugs in Different Age-Group Patients with Upper Gastrointestinal Bleeding

Table 3

Effect of antithrombotic drug application on prognosis of patients in the two groups.

		Elderly group			Young group
		Length of stay (days)	Rebleeding	Mortality	Length of stay (days)	Rebleeding	Mortality
History of AP	Y		6 (0.053%)	5 (0.044%)		0 (0%)	0 (0%)
	N		16 (0.049%)	15 (0.046%)		5 (0.021%)	1 (0.004%)
		0.154	0.865	0.939	0.100	0.400	0.709
History of AC	Y		0 (0%)	1 (0.091%)		0 (0%)	0 (0%)
	N		22 (0.051%)	19 (0.044%)		5 (0.019%)	1 (0.004%)
		0.277	0.443	0.459	0.148	0.891	0.951
AP after UGIB	Y		3 (0.058%)	2 (0.038%)		0 (0%)	0 (0%)
	N		19 (0.049%)	18 (0.046%)		5 (0.02%)	1 (0.004%)
		0.040	0.777	0.805	0.054	0.461	0.744
AC after UGIB	Y		6 (0.176%)	3 (0.088%)		0 (0%)	0 (0%)
	N		16 (0.039%)	17 (0.042%)		5 (0.019%)	1 (0.004%)
		<0.001	<0.001	0.208	0.609	0.713	0.870